|
Ethanone, 2-[5-[2-[(2,3-dihydro-1H-inden-2-yl)amino]-6-quinazolinyl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydro-5H-1,2,3-triazolo[4,5-c]pyridin-5-yl)- Suppliers list
|
Ethanone, 2-[5-[2-[(2,3-dihydro-1H-inden-2-yl)amino]-6-quinazolinyl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydro-5H-1,2,3-triazolo[4,5-c]pyridin-5-yl)- manufacturers
- ATX inhibitor 9
-
- $1980.00
-
2026-05-11
- CAS:2640300-87-2
- Purity:
- Supply Ability: 10g
|
| | Ethanone, 2-[5-[2-[(2,3-dihydro-1H-inden-2-yl)amino]-6-quinazolinyl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydro-5H-1,2,3-triazolo[4,5-c]pyridin-5-yl)- Basic information |
| Product Name: | Ethanone, 2-[5-[2-[(2,3-dihydro-1H-inden-2-yl)amino]-6-quinazolinyl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydro-5H-1,2,3-triazolo[4,5-c]pyridin-5-yl)- | | Synonyms: | Ethanone, 2-[5-[2-[(2,3-dihydro-1H-inden-2-yl)amino]-6-quinazolinyl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydro-5H-1,2,3-triazolo[4,5-c]pyridin-5-yl)-;ATX inhibitor 9 | | CAS: | 2640300-87-2 | | MF: | C26H23N9O2 | | MW: | 493.52 | | EINECS: | | | Product Categories: | | | Mol File: | 2640300-87-2.mol | ![Ethanone, 2-[5-[2-[(2,3-dihydro-1H-inden-2-yl)amino]-6-quinazolinyl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydro-5H-1,2,3-triazolo[4,5-c]pyridin-5-yl)- Structure](CAS/20210305/GIF/2640300-87-2.gif) |
| | Ethanone, 2-[5-[2-[(2,3-dihydro-1H-inden-2-yl)amino]-6-quinazolinyl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydro-5H-1,2,3-triazolo[4,5-c]pyridin-5-yl)- Chemical Properties |
| Boiling point | 854.9±75.0 °C(Predicted) | | density | 1.481±0.06 g/cm3(Predicted) | | pka | 8.61±0.20(Predicted) |
| | Ethanone, 2-[5-[2-[(2,3-dihydro-1H-inden-2-yl)amino]-6-quinazolinyl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydro-5H-1,2,3-triazolo[4,5-c]pyridin-5-yl)- Usage And Synthesis |
| Uses | ATX inhibitor 9 is a potent inhibitor of ATX. ATX inhibitor 9 is a thickened heteroaryl derivatives compound. Autotaxin (ATX), also known as ENPP2, is a secreted enzyme that is highly expressed mainly in cancer cells, bronchial epithelial cells and alveolar macrophages in the lung. ATX inhibitor 9 has the potential for the research of cancer or fibrous degenerative disease (extracted from patent WO2021078227A1, compound 3)[1]. | | References | [1] Xiaomin Zhang, et al. Thickened heteroaryl derivatives, their preparation methods and their application in medicine. |
| | Ethanone, 2-[5-[2-[(2,3-dihydro-1H-inden-2-yl)amino]-6-quinazolinyl]-1,3,4-oxadiazol-2-yl]-1-(3,4,6,7-tetrahydro-5H-1,2,3-triazolo[4,5-c]pyridin-5-yl)- Preparation Products And Raw materials |
|